Ihlen H, Simonsen S, Welzel D
Eur J Clin Pharmacol. 1984;27(1):29-34.
The effect of adrenaline on myocardial oxygen consumption (MVO2) during selective and non-selective beta-adrenoceptor blockade was examined in 26 patients with angina pectoris. Cardiac venous flow was measured by thermodilution and blood was sampled for metabolic studies. Thirteen patients were given atenolol 62.5 micrograms/kg i.v. and the other 13 patients pindolol 7.5 micrograms/kg i.v. Measurements were repeated before and during infusion of adrenaline 0.1 microgram/kg/min. Compared to the control situation, adrenaline increased MVO2 more in atenolol-treated (39%) than in pindolol-treated patients (11%). This was partly due to augmented external cardiac work. Arterial FFA was considerably increased in the atenolol group (105%), but was unchanged in the pindolol group, suggesting an additional metabolic mechanism. Thus, adrenaline stimulation, which is comparable to that found in acute myocardial infarction, increases MVO2 more during selective than non-selective beta-blockade.
在26例心绞痛患者中研究了选择性和非选择性β肾上腺素能受体阻滞剂对肾上腺素所致心肌耗氧量(MVO2)的影响。通过热稀释法测定心脏静脉血流,并采集血液进行代谢研究。13例患者静脉注射阿替洛尔62.5微克/千克,另外13例患者静脉注射吲哚洛尔7.5微克/千克。在输注肾上腺素0.1微克/千克/分钟之前和期间重复进行测量。与对照情况相比,肾上腺素使阿替洛尔治疗组的MVO2增加更多(39%),而吲哚洛尔治疗组增加较少(11%)。这部分归因于心脏外部做功增加。阿替洛尔组动脉游离脂肪酸(FFA)显著增加(105%),而吲哚洛尔组则无变化,提示存在额外的代谢机制。因此,与急性心肌梗死中发现的情况类似,肾上腺素刺激在选择性β受体阻滞期间比非选择性β受体阻滞期间使MVO2增加更多。